Characterisation and prevention of "Stunning", a cytotoxic T lymphocyte inactivating program that impairs adoptive cell therapy against cancer
This project seeks to identify the factors that turn off therapeutic cancer-killing immune cells in patients. The results will help us prepare more effective treatments using live anti-cancer cell therapies.
Prof Jose Villadangos, Prof William Heath
Cancer Council Research Grant
The University of Melbourne; Microbiology and Immunology
$100,000 pa for three years